Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Gopalakrishnan Ramakrishnan"'
Autor:
Catherine S. Blaha, Gopalakrishnan Ramakrishnan, Sang-Min Jeon, Veronique Nogueira, Hyunsoo Rho, Soeun Kang, Prashanth Bhaskar, Alexander R. Terry, Alexandre F. Aissa, Maxim V. Frolov, Krushna C. Patra, R. Brooks Robey, Nissim Hay
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-20 (2022)
Hexokinase 2 expression is markedly induced in cancer cells and contributes to cancer cell metabolism. Here, the authors show that hexokinase 2 can contribute to the metastatic spread of cancer cells independently of its glycolytic function via inhib
Externí odkaz:
https://doaj.org/article/78bfbaa457e843ebaad6087dacfee23a
Autor:
Pandi Anandakumar, Sattu Kamaraj, Sundaram Jagan, Gopalakrishnan Ramakrishnan, Selvamani Asokkumar, Chandrashekar Naveenkumar, Subramanian Raghunandhakumar, Manickam Kalappan Vanitha, Thiruvengadam Devaki
Publikováno v:
Journal of Pharmacopuncture, Vol 18, Iss 2, Pp 19-25 (2015)
Objectives: Capsaicin (CAP) is the chief pungent principle found in the hot red peppers and the chili peppers that have long been used as spices, food additives and drugs. This study investigated the anticancer potential of CAP through its ability to
Externí odkaz:
https://doaj.org/article/a72d2fca35274257ae11cb56d299585d
Autor:
Gopalakrishnan, Ramakrishnan1 ramankrg@med.usc.edu, Matta, Hittu1, Choi, Sunju1, Chaudhary, Preet M.1 preet.chaudhary@med.usc.edu
Publikováno v:
Scientific Reports. 3/31/2020, Vol. 10 Issue 1, p1-13. 13p.
Autor:
Natarajan, Venkatesh1, Gopalakrishnan, Ramakrishnan1, Matta, Hittu1, Choi, Sunju1, Gong, Songjie1, Jeronimo, Alberto1, Keerthipati, Pooja Smruthi1, Morales, Anthony1, Venkatesh, Harishwar1, Chaudhary, Preet M.1 preet.chaudhary@med.usc.edu
Publikováno v:
Scientific Reports. 2/11/2020, Vol. 10 Issue 1, p1-13. 13p.
Autor:
Subrahmanian Sathiavageesan, Balamurugan Swaminatha, Murugan Myvizhiselvi, Gopalakrishnan Ramakrishnan
Publikováno v:
SSRN Electronic Journal.
Autor:
Gopalakrishnan Ramakrishnan, Parash Parajuli, Pura Singh, Creighton Friend, Eric Hurwitz, Celine Prunier, Mohammed S. Razzaque, Keli Xu, Azeddine Atfi
Publikováno v:
Cell reports. 41(6)
A long-standing question in the pancreatic ductal adenocarcinoma (PDAC) field has been whether alternative genetic alterations could substitute for oncogenic KRAS mutations in initiating malignancy. Here, we report that Neurofibromin1 (NF1) inactivat
Autor:
Nayak, Ramesh C., Sen, Prosenjit, Ghosh, Samit, Gopalakrishnan, Ramakrishnan, Esmon, Charles T., Pendurthi, Usha R., Rao, L. Vijaya Mohan
Publikováno v:
In Blood 27 August 2009 114(9):1974-1986
Autor:
Gopalakrishnan Ramakrishnan, Alexandre Ferro Aissa, Rho H, Sang-Min Jeon, Robey Rb, Prashanth T. Bhaskar, Maxim V. Frolov, Krushna C. Patra, Nissim Hay, Nogueira, Catherine Blaha, Soeun Kang, Alexander R. Terry
Hexokinase 2 (HK2), a glycolytic enzyme that catalyzes the first committed step in glucose metabolism, is markedly induced in cancer cells. HK2’s role in tumorigenesis has been attributed to its glucose kinase activity. However, we uncovered a nove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8966f3dd7bce4517995971e56624f43
https://doi.org/10.1101/2021.04.08.439049
https://doi.org/10.1101/2021.04.08.439049
Autor:
Sang-Min Jeon, Prashanth T. Bhaskar, Brooks R.B. Robey, Alexander R. Terry, Hyunsoo Rho, Nissim Hay, Catherine Blaha, Soeun Kang, Gopalakrishnan Ramakrishnan, Alexandre Ferro Aissa, Maxim V. Frolov, Veronique Nogueira, Krushna C. Patra
Publikováno v:
SSRN Electronic Journal.
Hexokinase 2 (HK2), a glycolytic enzyme that catalyzes the first committed step in glucose metabolism, is markedly induced in cancer cells. HK2’s role in tumorigenesis has been attributed to its glucose kinase activity. However, we uncovered a nove
Autor:
Nissim Hay, Veronique Nogueira, Gopalakrishnan Ramakrishnan, Abul B. M. M. K. Islam, Xinyu Chen, William Putzbach, Catherine Blaha, Majd M. Ariss, Maxim V. Frolov
Publikováno v:
Mol Cell
Studies in three mouse models of breast cancer identified profound discrepancies between cell autonomous and systemic Akt1 or Akt2 deletion on breast cancer tumorigenesis and metastasis. First, unlike systemic Akt1 deletion, which inhibits metastasis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac0d54637f87898029103546c0d51247
https://europepmc.org/articles/PMC8291754/
https://europepmc.org/articles/PMC8291754/